Free Trial

Stevanato Group S.p.A. (NYSE:STVN) Shares Bought by Jennison Associates LLC

Stevanato Group logo with Medical background

Jennison Associates LLC grew its holdings in Stevanato Group S.p.A. (NYSE:STVN - Free Report) by 27.9% in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 1,188,057 shares of the company's stock after purchasing an additional 259,231 shares during the quarter. Jennison Associates LLC owned 0.39% of Stevanato Group worth $24,260,000 at the end of the most recent reporting period.

A number of other institutional investors also recently added to or reduced their stakes in the company. Whittier Trust Co. purchased a new position in Stevanato Group in the 1st quarter worth approximately $27,000. Johnson Financial Group Inc. bought a new position in Stevanato Group in the 4th quarter worth approximately $41,000. Wells Fargo & Company MN boosted its stake in Stevanato Group by 680.3% in the 4th quarter. Wells Fargo & Company MN now owns 3,246 shares of the company's stock valued at $71,000 after buying an additional 2,830 shares in the last quarter. PNC Financial Services Group Inc. boosted its stake in Stevanato Group by 1,457.6% in the fourth quarter. PNC Financial Services Group Inc. now owns 5,654 shares of the company's stock worth $123,000 after purchasing an additional 5,291 shares in the last quarter. Finally, Tower Research Capital LLC TRC increased its holdings in shares of Stevanato Group by 202.8% in the fourth quarter. Tower Research Capital LLC TRC now owns 7,413 shares of the company's stock worth $162,000 after acquiring an additional 4,965 shares in the last quarter.

Analyst Ratings Changes

Several research analysts have recently weighed in on STVN shares. William Blair reissued an "outperform" rating on shares of Stevanato Group in a research report on Monday, June 30th. Stephens raised Stevanato Group to a "strong-buy" rating in a research report on Monday, April 21st. Two analysts have rated the stock with a hold rating, four have issued a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average target price of €25.70 ($30.24).

Check Out Our Latest Report on Stevanato Group

Stevanato Group Trading Up 5.5%

STVN traded up €1.39 ($1.64) on Thursday, hitting €26.80 ($31.53). 380,584 shares of the company were exchanged, compared to its average volume of 326,414. The stock has a market capitalization of $8.12 billion, a PE ratio of 52.55, a price-to-earnings-growth ratio of 2.45 and a beta of 0.55. Stevanato Group S.p.A. has a 12 month low of €17.12 ($20.14) and a 12 month high of €27.23 ($32.04). The firm has a fifty day simple moving average of €24.08 and a two-hundred day simple moving average of €22.27. The company has a debt-to-equity ratio of 0.22, a quick ratio of 1.26 and a current ratio of 1.83.

Stevanato Group Increases Dividend

The firm also recently disclosed an annual dividend, which was paid on Thursday, July 17th. Stockholders of record on Thursday, June 5th were paid a $0.0613 dividend. This is a positive change from Stevanato Group's previous annual dividend of $0.05. The ex-dividend date was Thursday, June 5th. This represents a dividend yield of 0.3%.

Stevanato Group Profile

(Free Report)

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.

Featured Articles

Institutional Ownership by Quarter for Stevanato Group (NYSE:STVN)

Should You Invest $1,000 in Stevanato Group Right Now?

Before you consider Stevanato Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Stevanato Group wasn't on the list.

While Stevanato Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Stocks Set to Soar in Summer 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Joby vs. Archer: The $10 Billion eVTOL Battle
3 Small-Cap Biotech Stocks With Catalysts Too Big to Ignore
AI Stocks Are Printing Money — These 3 Are Just Getting Started

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines